Insider Transactions Reported by 18 Insiders of Bolt Biotherapeutics, Inc.

Symbol
BOLT on Nasdaq
Location
Redwood City, CA

Insiders trading volume in the past year

Bolt Biotherapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Vivo Capital VIII, LLC 10%+ Owner $5,435,517 21 Nov 2023
Novo Holdings A/S 10%+ Owner $3,518,791 13 Jul 2022
EDGAR ENGLEMAN Director $1,969,355 29 Nov 2023
Grant Yonehiro Chief Operating Officer $214,049 28 Jan 2026
Edith A. Perez Chief Medical Officer $36,451 04 Mar 2024
William P. Quinn President, CEO and CFO, Director $10,655 +$1,262 +13% 28 Jan 2026
Randall C. Schatzman Chief Executive Officer, Director $10,056 04 Mar 2024
Sarah Nemec Senior VP, Finance and PAO $6,518 +$1,262 +24% 28 Jan 2026
Frank D. Lee Director 12 Jun 2024
David Dornan Chief Scientific Officer 18 Feb 2022
JAMES HEALY Director 12 Jun 2024
KATHLEEN LAPORTE Director 12 Dec 2025
MAHENDRA SHAH Director 12 Jun 2024
NICOLE ONETTO Director 12 Dec 2025
Jakob Dupont Director 12 Dec 2025
BRIAN O'CALLAGHAN Director 12 Dec 2025
RICHARD A. MILLER MD Director 12 Jun 2023
Laura Berner Director 12 Dec 2025

Recent Insider Transactions by Companies or Individuals for Bolt Biotherapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.